View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Nivolumab 1 / Ipilimumab 3, Malignant Melanoma
Protocol-ID: 711 V1.2 (Mini), NIVO1/IPIL3, MelanomaIndication(s)
- Melanoma, Malignant; ICD-10 C44.-
Links
- Nivolumab (opdivo) [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 29.01.2023